Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Burdensome Research Procedures in Trials: Why Less Is More.

Kimmelman J, Resnik DB, Peppercorn J, Ratain MJ.

J Natl Cancer Inst. 2017 Apr 1;109(4). doi: 10.1093/jnci/djw315.

2.

Survey of users of TOPS, an internet-based system to prevent healthy subjects from over-volunteering for clinical trials.

Boyce M, Walther M, Kirk J, Smith S, Warrington S.

Eur J Clin Pharmacol. 2013 Oct;69(10):1757-60. doi: 10.1007/s00228-013-1534-4. Epub 2013 Jun 7.

PMID:
23743779
3.

Clinical research with healthy volunteers: an ethical framework.

Miller FG.

J Investig Med. 2003 Feb;51 Suppl 1:S2-5.

PMID:
12664947
4.

Sham neurosurgical procedures in clinical trials for neurodegenerative diseases: scientific and ethical considerations.

Galpern WR, Corrigan-Curay J, Lang AE, Kahn J, Tagle D, Barker RA, Freeman TB, Goetz CG, Kieburtz K, Kim SY, Piantadosi S, Comstock Rick A, Federoff HJ.

Lancet Neurol. 2012 Jul;11(7):643-50. doi: 10.1016/S1474-4422(12)70064-9.

PMID:
22710757
5.

Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct benefit.

Wendler D, Belsky L, Thompson KM, Emanuel EJ.

JAMA. 2005 Aug 17;294(7):826-32.

PMID:
16106008
6.

Pediatric research and the federal minimal risk standard.

Ross LF, Nelson RM.

JAMA. 2006 Feb 15;295(7):759; author reply 759-60. No abstract available.

PMID:
16478898
7.

Sham neurosurgical procedures: the patients' perspective.

Cohen PD, Isaacs T, Willocks P, Herman L, Stamford J, Riggare S, Wittekind P.

Lancet Neurol. 2012 Dec;11(12):1022. doi: 10.1016/S1474-4422(12)70277-6. No abstract available.

PMID:
23153402
8.

Commentary on the EMA Guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products.

van Gerven J, Bonelli M.

Br J Clin Pharmacol. 2018 Jul;84(7):1401-1409. doi: 10.1111/bcp.13550. Epub 2018 May 30. No abstract available.

9.

Sham surgery and genuine standards of care: can the two be reconciled?

London AJ, Kadane JB.

Am J Bioeth. 2003 Autumn;3(4):61-4. No abstract available.

PMID:
14744339
10.

International codes of research ethics: current controversies and the future.

Levine RJ.

Indiana Law Rev. 2002;35(2):557-67. No abstract available.

PMID:
16189916
11.

The ubiquity and utility of the therapeutic misconception.

Dresser R.

Soc Philos Policy. 2002 Summer;19(2):271-94. No abstract available.

PMID:
12678090
12.

Medical studies and the average American kid.

Weiss R.

Washington Post. 2005 Aug 22:A5. No abstract available.

PMID:
16138447
13.

Analysis of consent validity for invasive, nondiagnostic research procedures.

Kimmelman J, Lemmens T, Kim SY.

IRB. 2012 Sep-Oct;34(5):1-7. No abstract available.

PMID:
23072039
14.

Assessing research risks systematically: the net risks test.

Wendler D, Miller FG.

J Med Ethics. 2007 Aug;33(8):481-6.

15.

Uniqueness, exploitation, and relative risk standards in adolescent research.

Malek J.

Am J Bioeth. 2011 Jun;11(6):23-5. doi: 10.1080/15265161.2011.568587. No abstract available.

PMID:
21678211
16.

The concept of minimal risk: the need for better guidance on the ethics review process.

Wada K.

Am J Bioeth. 2011 Jun;11(6):27-9. doi: 10.1080/15265161.2011.568584. No abstract available.

PMID:
21678213
17.

Regulating "higher risk, no direct benefit" studies in minors.

Westra AE, Wit JM, Sukhai RN, de Beaufort ID.

Am J Bioeth. 2011 Jun;11(6):29-31. doi: 10.1080/15265161.2011.566669. No abstract available.

PMID:
21678214
18.

Sham surgery: to cut or not to cut--that is the ethical dilemma.

Clark PA.

Am J Bioeth. 2003 Autumn;3(4):66-8. No abstract available.

PMID:
14744341
19.

TOPS: an internet-based system to prevent healthy subjects from over-volunteering for clinical trials.

Boyce M, Walther M, Nentwich H, Kirk J, Smith S, Warrington S.

Eur J Clin Pharmacol. 2013 Mar;69(3):731. doi: 10.1007/s00228-012-1351-1. Epub 2012 Sep 12. No abstract available.

PMID:
22968810
20.

TOPS: an internet-based system to prevent healthy subjects from over-volunteering for clinical trials.

Boyce M, Walther M, Nentwich H, Kirk J, Smith S, Warrington S.

Eur J Clin Pharmacol. 2012 Jul;68(7):1019-24. doi: 10.1007/s00228-012-1231-8. Epub 2012 Feb 17.

Supplemental Content

Support Center